SCARB2 and hepatocellular carcinoma: We found that SCARB2 overexpression further increased MYC acetylation in p300-, KAT5-, or GCN5 silencing HCC cells (Supplementary Fig. 4d), suggesting that one or more additional acetyltransferases or deacetylases may be involved in this SCARB2-regulated process.